Efficacy evaluation of Unani formulation in pain during menstrual cycle.
Phase 2
- Conditions
- Health Condition 1: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2023/07/055235
- Lead Sponsor
- uqman Unani Medical College Hospital and Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Married and unmarried patients between 15 to 35 years of ages having regular menstrual cycles
Patient diagnosed with primary dysmenorrhea
Patients with Visual Analog Scale less than or equal to 4cm for at least three menstrual cycles before this study
Exclusion Criteria
Pelvic disease such as fibroid adenomyosis PID endometrial polyp ovarian tumour
Irregular menstrual cycles
Pregnancy and lactation
Systemic illness
Oral contraceptives and those Wearing IUCD devices
Participants with congenital anomalies of uterus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Severity of pain determined by VAS <br/ ><br>Change in duration of menstrual painTimepoint: before after treatment
- Secondary Outcome Measures
Name Time Method Change in HRQoL determined by SF-12 v1 health survey questionnaire <br/ ><br>Change in PBLAC score for menstrual blood lossTimepoint: before after treatment